203 related articles for article (PubMed ID: 19424558)
1. Clinical characteristics of patients with Acinetobacter junii infection.
Hung YT; Lee YT; Huang LJ; Chen TL; Yu KW; Fung CP; Cho WL; Liu CY
J Microbiol Immunol Infect; 2009 Feb; 42(1):47-53. PubMed ID: 19424558
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
4. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases.
Lin SY; Wong WW; Fung CP; Liu CE; Liu CY
J Microbiol Immunol Infect; 1998 Jun; 31(2):119-24. PubMed ID: 10596990
[TBL] [Abstract][Full Text] [Related]
5. Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Tsai HY; Cheng A; Liu CY; Huang YT; Lee YC; Liao CH; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2737-43. PubMed ID: 22562410
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification.
Chiang DH; Wang CC; Kuo HY; Chen HP; Chen TL; Wang FD; Cho WL; Liu CY
J Microbiol Immunol Infect; 2008 Oct; 41(5):397-402. PubMed ID: 19122921
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia.
Chen CH; Lin LC; Chang YJ; Huang CC; Liu CE; Young TG
Infection; 2003 Oct; 31(5):331-5. PubMed ID: 14556059
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of Acinetobacter species isolated from cerebrospinal fluid.
Chen HP; Lai CH; Chan YJ; Chen TL; Liu CY; Fung CP; Liu CY
Scand J Infect Dis; 2005; 37(9):669-75. PubMed ID: 16126568
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of and risk factors for Acinetobacter species bloodstream infection in children.
Segal SC; Zaoutis TE; Kagen J; Shah SS
Pediatr Infect Dis J; 2007 Oct; 26(10):920-6. PubMed ID: 17901798
[TBL] [Abstract][Full Text] [Related]
11. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
[TBL] [Abstract][Full Text] [Related]
12. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG
J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan.
Chang PY; Hsueh PR; Wu PS; Chan PC; Yang TT; Lu CY; Chang LY; Chen JM; Lee PI; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Oct; 40(5):406-10. PubMed ID: 17932600
[TBL] [Abstract][Full Text] [Related]
15. Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis.
Smego RA
Arch Intern Med; 1985 Dec; 145(12):2174-9. PubMed ID: 4074029
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium bacteremia: clinical significance and outcomes.
Su CP; Huang PY; Yang CC; Lee MH
J Microbiol Immunol Infect; 2009 Aug; 42(4):336-42. PubMed ID: 19949758
[TBL] [Abstract][Full Text] [Related]
17. A case of community-acquired Acinetobacter junii-johnsonii cellulitis.
Henao-Martínez AF; González-Fontal GR; Johnson S
Biomedica; 2012 Jun; 32(2):179-81. PubMed ID: 23242290
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
Lee IK; Liu JW
J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
[TBL] [Abstract][Full Text] [Related]
19. Clinical experiences of pulmonary and bloodstream nocardiosis in two tertiary care hospitals in northern Taiwan, 2000-2004.
Tuo MH; Tsai YH; Tseng HK; Wang WS; Liu CP; Lee CM
J Microbiol Immunol Infect; 2008 Apr; 41(2):130-6. PubMed ID: 18473100
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
